Search results
Results from the WOW.Com Content Network
But this is still a growth stock investors should watch, which Travis Hoium explains in this video. *Stock prices used were end-of-day prices of Dec. 18, 2024. The video was published on Dec. 19 ...
Why Hims & Hers Stock Jumped on Massive FDA News. Travis Hoium, The Motley Fool. November 26, 2024 at 9:07 AM. ... *Stock prices used were end-of-day prices of Nov. 25, 2024. The video was ...
Hims & Hers may not be hurt by GLP-1 news the way investors think. ... *Stock prices used were end-of-day prices of Oct. 3, 2024. The video was published on Oct. 3, 2024. ...
The market thinks this is terrible news, but is it? Travis Hoium covers the industry dynamics in this video. *Stock prices used were end-of-day prices of Nov. 14, 2024.
The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. See the 10 stocks » *Stock Advisor returns as of October 21, 2024. Travis Hoium has positions in Hims & Hers ...
Price Action: HIMS stock is up 5.77% at $28.23 at the last check Wednesday. Read Next: Boeing Forecasts 67% Growth In Global Air Cargo Fleet By 2043, Driven By Asia Demand
The news was seen as a competitive threat to Hims & Hers, and a number of other pharmacies, and shares of Hims & Hers fell 9.2% on Tuesday and lost 12% for the week as of Thursday's close.
The stock price has fallen so much that it's like the GLP-1 hype train never left the station. Remember that Hims & Hers did $315.6 million in Q2 sales; roughly $15 million came from GLP-1s. Is ...